Very early researchUnknownNCT04412889What this trial is testingBCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MMWho this might be right forMultiple Myeloma Hebei Yanda Ludaopei Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT03875495What this trial is testingA Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)Who this might be right forMultiple Myeloma Genenta Science 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687004What this trial is testingSonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic StratificationWho this might be right forMultiple Myeloma (MM) Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableNot Yet RecruitingNCT07634263What this trial is testingWhy Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods StudyWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaMultiple Myeloma ProgressionMultiple Myeloma Refractory Odense University Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT01303965What this trial is testingAllo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Sherif S. Farag 14
Early research (Phase 1)Ended earlyNCT05153330What this trial is testingStudy of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Mixed-Phenotype Leukemia+12 more Biomea Fusion Inc. 55
Testing effectiveness (Phase 2)Looking for participantsNCT06292780What this trial is testingA Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)Who this might be right forRelapsed/Refractory Systemic Light Chain Amyloidosis Regeneron Pharmaceuticals 220
Not applicableLooking for participantsNCT06961669What this trial is testingIntravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaWho this might be right forLymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM) Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06832865What this trial is testingELISA in Relapsed/Refractory MMWho this might be right forRelapsed Refractory Multiple Myeloma (RRMM)Relapsed Refractory Multiple Myeloma Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01753453What this trial is testingAn Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem CellsWho this might be right forMultiple Myeloma Sanofi 23
Testing effectiveness (Phase 2)UnknownNCT01325896What this trial is testingMaintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)Who this might be right forMultiple Mieloma Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 33
Early research (Phase 1)Ended earlyNCT04702425What this trial is testingVOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)Who this might be right forNon-Hodgkin Lymphoma (NHL)Acute Myeloid Leukemia (AML)Multiple Myeloma (MM) Novartis Pharmaceuticals 37
Not applicableLooking for participantsNCT07051850What this trial is testingQuality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional ImmunotherapiesWho this might be right forMultiple Myeloma, RelapsedMultiple Myeloma (MM) Sung-Soo Park 174
Not applicableNo Longer AvailableNCT00999414What this trial is testingUARK 2009-32 Compassionate Use Study of CarfilzomibWho this might be right forMultiple Myeloma University of Arkansas
Large-scale testing (Phase 3)Active Not RecruitingNCT04975997What this trial is testingOpen-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma Celgene 939
Not applicableNot Yet RecruitingNCT07015021What this trial is testingThe Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM PatientsWho this might be right forMultiple MyelomaCarfilzomibDaratumumab+1 more The First Affiliated Hospital of Soochow University 72
Early research (Phase 1)Not Yet RecruitingNCT07725406What this trial is testingLow-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple MyelomaWho this might be right forRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed or Refractory Multiple Myeloma (MM) Weill Medical College of Cornell University 32
Not applicableUnknownNCT04004338What this trial is testingCarfilzomib in Combination for the Treatment of RR MMWho this might be right forMultiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma Black Sea Hematology Association 300
Testing effectiveness (Phase 2)Study completedNCT01531998What this trial is testingLenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)Who this might be right forMyeloma M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT02899052What this trial is testingStudy of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)Who this might be right forMultiple Myeloma AbbVie 120